IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control apoptosis. Its products under Phase 2 and preclinical trials include drugs for liver disease, CNS diseases, inflammation, and cancer, as well as IDN-6556 for the treatment of liver diseases in patients infected with Hepatitis C virus. The company was founded in 1993 and is based in San Diego, California. As of July 30, 2010, IDUN Pharmaceuticals, Inc. operates as a subsidiary of Conatus Pharmaceuticals Inc.

The University of California is the nation's best public university system, delivering top-notch research and innovation to California (and the world).

Merck Sharp & Dohme Corp. engages in the research, development, and distribution of vaccines, prescription drugs, and animal health products. The company is headquartered in Whitehouse Station, NJ.

Schering Corp. manufactures pharmaceutical products. It offers products in the areas of allergy and respiratory, anti-infectives, foot care, hepatitis, skin disorders, and sun care. It is a subsidiary of Schering-Plough Corp. The company is headquartered in Kenilworth, NY.

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Ischemix, Inc., a pharmaceutical company, develops small molecule drugs for the treatment and prevention of ischemia-reperfusion injury. Its product includes CMX-2043, a cardio-protective drug that combines Akt pathway-mediated cell survival effects and anti-oxidant activity in a single small molecule, as well as is used for the prevention of peri-operative ischemia-reperfusion injury in patients undergoing elective percutaneous coronary intervention procedures. The company’s drugs also protect against the damaging effects associated with ischemia in brain and other organs. Ischemix, Inc. was formerly known as CereMedix, Inc. and changed its name to Ischemix, Inc. in February 2006. The company was founded in 1999 and is headquartered in Maynard, Massachusetts.

Smithkline Beckman Corp, part of GSK Plc, is an American company located in Philadelphia, PA, involved in pharmaceutical preparations. On July 27, 1989 Smithkline Beecham Plc acquired Smithkline Beckman Corp for $16,082.37 million.

Part of Sanofi, Aventis Pharma SARL is a French company located in Antony. The firm manufactures pharmaceuticals. It was founded in 1982.

UMC Utrecht Holding BV engages in utilization and commercialization of academic researches. It offers research support and training services. The company was founded in 1996 and is headquartered in Utrecht, the Netherlands.

Aventis Pharma Deutschland GmbH produces pharmaceutical products. It offers prescription drugs, human vaccines, and therapeutic proteins businesses. Aventis Pharma Deutschland plans and designs plants and process control systems in the areas of active ingredients production and finished drugs. The company is headquartered in Frankfurt am Main, Germany.

BREONICS’ Exsanguinous Metabolic Support (EMS) technology radically broadens the criteria for organ donors to include the huge cohort of patients that die every year and are previously not considered for donation. EMS is the first and only technology that can overcome the technical barriers that limit access to these potential donors and will more than double the number of transplantable kidneys worldwide.

Sanofi is a global healthcare company. Among their duties are researching disease causes, determining starting points for drug treatment, developing drugs, producing active ingredients, and delivering finished drugs and active ingredients. Specialists in vaccines, rare diseases, rare blood disorders, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare.

Part of Keck Seng Investments (Hong Kong) Ltd., Compton Developments Ltd. is an of the British Virgin Islands company that engages in real estate development and investment holdings.

S.Biomedics Co. Ltd. operates as a biotechnology company. It engages in the research and development of cell therapies for regenerative biomedicine. The company was founded in August 2003 and is headquartered in Seoul, South Korea.

innoVision Holding Ltd is a Chinese private company. The firm provides information technology services.

Medcool, Inc. is a medical products company that develops and manufactures non-invasive, proprietary therapeutic temperature reduction solutions for emergency medicine and intensive care applications. The company was founded by Charles Lennox and Helen Maslocka in 2002 and is headquartered in Wellesley, MA.

Rhone-Poulenc Rorer, Inc. discovers, develops and markets human pharmaceuticals. It operates in all major markets of the world. The company is headquartered in Collegeville, PA.

Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution, and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals, and Nutritionals. The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.